CNR vs CSAN

CNR exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite massive YoY revenue growth of 81.80% following the Arch merger, the company is struggling with negative profit margins (-3.68%) and a catastrophic YoY EPS decline of -248.1%. The divergence between bullish analyst targets ($112.25) and aggressive insider selling ($6.72M) suggests a significant disconnect between market expectations and internal sentiment. Operational risks, specifically the combustion events at the Leer South mine, further compound the bearish outlook.

CSAN exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the company maintains strong liquidity (Current Ratio 2.58) and impressive operating margins (30.71%), these are completely offset by a negative net profit margin of -24.05% and a catastrophic YoY EPS decline of -712.5%. The stock is in a long-term technical downtrend, losing over 72% of its value over five years, and consistently misses earnings estimates. Despite a low Price/Sales ratio, the negative ROE and poor earnings quality make the current valuation risky.